Decoding the Impact of Inflation Reduction Act on US Drug Prices
TL/DR -
The Inflation Reduction Act (IRA), introduced in 2022, caps out-of-pocket expenses for brand-name drugs for Medicare beneficiaries and lets Medicare negotiate prices for certain expensive drugs. The law is predicted to save Medicare Part D enrollees substantial amounts from 2025 by removing the 5% co-insurance requirement and setting a…